{"DataElement":{"publicId":"3540249","version":"1","preferredName":"Immunohistochemistry Staining Biomarker Name","preferredDefinition":"Text name of a biomarker used in immunohistochemistry (IHC) analysis.","longName":"3536320v1.0:3540236v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3536320","version":"1","preferredName":"Immunohistochemistry Staining Method Biomarker","preferredDefinition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen._Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc","longName":"3540227v1.0:2437715v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3540227","version":"1","preferredName":"Immunohistochemistry Staining Method","preferredDefinition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","longName":"C23020","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunohistochemistry Staining Method","conceptCode":"C23020","definition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C64CB2C9-0055-B5CD-E040-BB89AD436DA3","latestVersionIndicator":"Yes","beginDate":"2012-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-02","modifiedBy":"ONEDATA","dateModified":"2012-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2437715","version":"1","preferredName":"Biomarker","preferredDefinition":"Objectively measurable phenotypic parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype, presence of biological substances) that characterize an organism's state of health or disease, likelihood of developing a disease, or response to a particular therapeutic intervention.","longName":"C16342","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07F9A427-79F8-5E87-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-15","endDate":null,"createdBy":"UMLLOADER_CAMOD","dateCreated":"2005-12-15","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C60BB744-AF02-40C1-E040-BB89AD432BF7","latestVersionIndicator":"Yes","beginDate":"2012-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-30","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3540236","version":"1","preferredName":"Immunohistochemistry Staining Method Biomarker Name","preferredDefinition":"Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc_The words or language units by which a thing is known.","longName":"3540236v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Ki-67","valueDescription":"Proliferation-Related Ki-67 Antigen","ValueMeaning":{"publicId":"3009658","version":"1","preferredName":"Proliferation-Related Ki-67 Antigen","longName":"3009658","preferredDefinition":"Antigen Identified by Monoclonal Antibody Ki-67, encoded by the MKI67 gene, is a nuclear antigen expressed in proliferating cells but not in quiescent cells, and required for maintaining cell proliferation. Expression of this antigen occurs preferentially during late G1, S, G2, and M phases of the cell cycle, while in cells in G0 phase the antigen cannot be detected. Consequently, the monoclonal antibody Ki-67 is used in tumor pathology to detect proliferating cells in neoplastic diseases. This antigen is located in the nucleus, predominantly localized in the G1 phase in the perinucleolar region. In the later phases it is also detected throughout the nuclear interior, being predominantly localized in the nuclear matrix. In mitosis, it is present on all chromosomes. This antigen contains 1 FHA domain. Two alternative splicing forms exist, Long and Short. (from Swiss-Prot) ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antigen KI-67","conceptCode":"C17675","definition":"Antigen KI-67 protein (3256 aa, ~359 kDa) is encoded by the human MKI67 gene. This protein is required for cell proliferation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F6AE9B9-9530-559F-E040-BB89AD437EAB","latestVersionIndicator":"Yes","beginDate":"2010-02-12","endDate":null,"createdBy":"LOHNESC","dateCreated":"2010-02-12","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C64D85C5-7527-4BF3-E040-BB89AD4309F1","beginDate":"2012-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-02","modifiedBy":"ONEDATA","dateModified":"2012-08-02","deletedIndicator":"No"},{"value":"CD79a","valueDescription":"CD79A Gene","ValueMeaning":{"publicId":"3540238","version":"1","preferredName":"CD79A Gene","longName":"3540238","preferredDefinition":"This gene is involved in B-cell signaling and proliferation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD79A Gene","conceptCode":"C97421","definition":"This gene is involved in B-cell signaling and proliferation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C64D85C5-7534-4BF3-E040-BB89AD4309F1","latestVersionIndicator":"Yes","beginDate":"2012-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-02","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C64D85C5-754D-4BF3-E040-BB89AD4309F1","beginDate":"2012-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-02","modifiedBy":"ONEDATA","dateModified":"2012-08-02","deletedIndicator":"No"},{"value":"CD3","valueDescription":"CD3 Complex","ValueMeaning":{"publicId":"3540239","version":"1","preferredName":"CD3 Complex","longName":"3540239","preferredDefinition":"Consisting of cell surface type I membrane Delta, Epsilon, Gamma, Zeta, and Eta protein subunits with ITAM domains and noncovalently associated with the disulfide bound heterodimeric alpha/beta and gamma/delta TCR, the CD3 complex couples receptor antigen recognition to signal transduction pathways during T-cell activation. During TCR engagement with MHC-associated antigen on host cell surfaces and synapse formation, CD3 activity leads to Tyr-phosphorylated CD3 subunits, Tyr phosphorylation of LAT colocalized in lipid rafts, and MAPK activation. CD3 signal transduction appears to involve LCK, ZAP70, Nck, SLA, SLA2, and DOCK2. CD3 subunits may also associate with the cytoskeleton. CD3 also mediates TCR signal transduction during the developmental transition through positive selection of immature thymocytes to mature CD4+ or CD8+ T cells. (NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD3 Complex","conceptCode":"C38897","definition":"A protein complex comprised of one T-cell surface glycoprotein CD3 delta chain (CD3D), one T-cell surface glycoprotein CD3 gamma chain (CD3G) and two T-cell surface glycoprotein CD3 epsilon chains (CD3E). CD3D, CD3G and CD3E are transmembrane proteins with one extracellular immunoglobulin domain and one intracellular ITAM domain. The CD3 complex is a T-cell co-receptor that noncovalently associates with either the disulfide bound heterodimeric alpha/beta T-cell receptor (TCR) or gamma/delta TCR and two copies of the accessory protein, T-cell surface glycoprotein CD3 zeta chain (CD247), which is a transmembrane protein with three ITAM domains. The TCR moiety of the TCR-CD3 complex binds to MHC and processed antigens on antigen presenting cells, which triggers phosphorylation of and cellular propagation of the signal by CD247 and the CD3 complex.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C64D85C5-7557-4BF3-E040-BB89AD4309F1","latestVersionIndicator":"Yes","beginDate":"2012-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C64D85C5-756F-4BF3-E040-BB89AD4309F1","beginDate":"2012-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-02","modifiedBy":"ONEDATA","dateModified":"2012-08-02","deletedIndicator":"No"},{"value":"CDKN3 Gene","valueDescription":"CDKN3 Gene","ValueMeaning":{"publicId":"3540241","version":"1","preferredName":"CDKN3 Gene","longName":"3540241","preferredDefinition":"This gene plays a role in cell cycle regulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDKN3 Gene","conceptCode":"C24289","definition":"This gene plays a role in cell cycle regulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C64D85C5-757D-4BF3-E040-BB89AD4309F1","latestVersionIndicator":"Yes","beginDate":"2012-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-02","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C64D85C5-7596-4BF3-E040-BB89AD4309F1","beginDate":"2012-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-02","modifiedBy":"ONEDATA","dateModified":"2012-08-02","deletedIndicator":"No"},{"value":"CD10","valueDescription":"CD10 count","ValueMeaning":{"publicId":"3540243","version":"1","preferredName":"CD10 count","longName":"3540243","preferredDefinition":"No Value Exists","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD10 count","conceptCode":"C1271896","definition":"No Value Exists","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C64D85C5-75A3-4BF3-E040-BB89AD4309F1","latestVersionIndicator":"Yes","beginDate":"2012-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C64D85C5-75BC-4BF3-E040-BB89AD4309F1","beginDate":"2012-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-02","modifiedBy":"ONEDATA","dateModified":"2012-08-02","deletedIndicator":"No"},{"value":"CD20","valueDescription":"CD20 Antigen","ValueMeaning":{"publicId":"3540244","version":"1","preferredName":"CD20 Antigen","longName":"3540244","preferredDefinition":"B-lymphocyte antigen CD20 (297 aa, ~33 kDa) is encoded by the human MS4A1 gene. This protein plays a role in both the activation and proliferation of B-cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B-Lymphocyte Antigen CD20","conceptCode":"C38896","definition":"B-lymphocyte antigen CD20 (297 aa, ~33 kDa) is encoded by the human MS4A1 gene. This protein plays a role in both the activation and proliferation of B-cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C64D85C5-75C6-4BF3-E040-BB89AD4309F1","latestVersionIndicator":"Yes","beginDate":"2012-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C64D85C5-75DF-4BF3-E040-BB89AD4309F1","beginDate":"2012-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-02","modifiedBy":"ONEDATA","dateModified":"2012-08-02","deletedIndicator":"No"},{"value":"TP53","valueDescription":"TP53 Gene","ValueMeaning":{"publicId":"3540245","version":"1","preferredName":"TP53 Gene","longName":"3540245","preferredDefinition":"A tumor suppressor gene that normally inhibits the growth of tumors. This gene is altered in many types of cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 Gene","conceptCode":"C17359","definition":"This gene plays a critical role in cell cycle regulation and has tumor suppressor activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C64D85C5-75E9-4BF3-E040-BB89AD4309F1","latestVersionIndicator":"Yes","beginDate":"2012-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C64D85C5-7601-4BF3-E040-BB89AD4309F1","beginDate":"2012-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-02","modifiedBy":"ONEDATA","dateModified":"2012-08-02","deletedIndicator":"No"},{"value":"MUM1","valueDescription":"MUM1 gene","ValueMeaning":{"publicId":"3540246","version":"1","preferredName":"MUM1 gene","longName":"3540246","preferredDefinition":"Human IRF4 wild-type allele is located within 6p25-p23 and is approximately 20 kb in length. This allele, which encodes interferon regulatory factor 4 protein, plays a role in lymphocyte proliferation and maturation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MUM1 gene","conceptCode":"C1428883","definition":"Human IRF4 wild-type allele is located within 6p25-p23 and is approximately 20 kb in length. This allele, which encodes interferon regulatory factor 4 protein, plays a role in lymphocyte proliferation and maturation.","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C64D85C5-760C-4BF3-E040-BB89AD4309F1","latestVersionIndicator":"Yes","beginDate":"2012-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C64D85C5-7624-4BF3-E040-BB89AD4309F1","beginDate":"2012-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-02","modifiedBy":"ONEDATA","dateModified":"2012-08-02","deletedIndicator":"No"},{"value":"BCL2","valueDescription":"BCL2 Gene","ValueMeaning":{"publicId":"3540247","version":"1","preferredName":"BCL2 Gene","longName":"3540247","preferredDefinition":"A protein that helps control whether a cell lives or dies by blocking a type of cell death called apoptosis. The gene for BCL2 is found on chromosome 18, and transfer of the BCL2 gene to a different chromosome is seen in many B-cell leukemias and lymphomas. This causes the BCL2 protein to be made in larger amounts, which may keep cancer cells from dying.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCL2 Gene","conceptCode":"C17963","definition":"This gene is involved in apoptotic regulation. Overexpression of this gene promotes the pathogenesis of B-Cell lymphomas, due to anti-apoptotic activity.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C64D85C5-762F-4BF3-E040-BB89AD4309F1","latestVersionIndicator":"Yes","beginDate":"2012-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C64D85C5-7647-4BF3-E040-BB89AD4309F1","beginDate":"2012-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-02","modifiedBy":"ONEDATA","dateModified":"2012-08-02","deletedIndicator":"No"},{"value":"BCL6","valueDescription":"BCL6 Gene","ValueMeaning":{"publicId":"3540248","version":"1","preferredName":"BCL6 Gene","longName":"3540248","preferredDefinition":"This gene is involved in transcriptional repression and plays a role in the modulation of B-cell responses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCL6 Gene","conceptCode":"C24260","definition":"This gene is involved in transcriptional repression and plays a role in the modulation of B-cell responses.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C64D85C5-7652-4BF3-E040-BB89AD4309F1","latestVersionIndicator":"Yes","beginDate":"2012-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C64D85C5-766A-4BF3-E040-BB89AD4309F1","beginDate":"2012-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-02","modifiedBy":"ONEDATA","dateModified":"2012-08-02","deletedIndicator":"No"},{"value":"Ap2beta","valueDescription":"Transcription Factor AP-2-Beta","ValueMeaning":{"publicId":"5178108","version":"1","preferredName":"Transcription Factor AP-2-Beta","longName":"5178108","preferredDefinition":"Transcription factor AP-2-beta (460 aa, ~50 kDa) is encoded by the human TFAP2B gene. This protein plays a role in transcriptional regulation, face and limb development, and differentiation and function of renal tubules.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transcription Factor AP-2-Beta","conceptCode":"C17970","definition":"Transcription factor AP-2-beta (460 aa, ~50 kDa) is encoded by the human TFAP2B gene. This protein plays a role in transcriptional regulation, face and limb development, and differentiation and function of renal tubules.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E57B40E-8D40-32A0-E050-BB89AD4318CC","latestVersionIndicator":"Yes","beginDate":"2016-03-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2E57B40E-8D59-32A0-E050-BB89AD4318CC","beginDate":"2016-03-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-03-18","modifiedBy":"ONEDATA","dateModified":"2016-03-18","deletedIndicator":"No"},{"value":"Myogenin staining","valueDescription":"Myogenin Staining","ValueMeaning":{"publicId":"5177993","version":"1","preferredName":"Myogenin Staining","longName":"5177993","preferredDefinition":"Myogenin (224 aa, ~25 kDa) is encoded by the human MYOG gene. This protein is involved in both transcription and myogenesis.: Discoloration of patient tissue(s) produced by absorption of, or contact with, foreign matter, such as with medical dyes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myogenin","conceptCode":"C94704","definition":"Myogenin (224 aa, ~25 kDa) is encoded by the human MYOG gene. This protein is involved in both transcription and myogenesis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Staining","conceptCode":"C50753","definition":"Discoloration of patient tissue(s) produced by absorption of, or contact with, foreign matter, such as with medical dyes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E581CB6-3162-4BA6-E050-BB89AD4322D6","latestVersionIndicator":"Yes","beginDate":"2016-03-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2E581CB6-317B-4BA6-E050-BB89AD4322D6","beginDate":"2016-03-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-03-18","modifiedBy":"ONEDATA","dateModified":"2016-03-18","deletedIndicator":"No"},{"value":"HMGA2","valueDescription":"HMGA2 Gene","ValueMeaning":{"publicId":"3691008","version":"1","preferredName":"HMGA2 Gene","longName":"3691008","preferredDefinition":"This gene is involved in chromatin organization and regulation of gene transcription. It also plays a role in development.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HMGA2 Gene","conceptCode":"C20577","definition":"This gene is involved in chromatin organization and regulation of gene transcription. It also plays a role in development.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D6A8531F-A5A0-A4E9-E040-BB89AD43785B","latestVersionIndicator":"Yes","beginDate":"2013-02-26","endDate":null,"createdBy":"COLBERTM","dateCreated":"2013-02-26","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2E581CB6-3185-4BA6-E050-BB89AD4322D6","beginDate":"2016-03-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-03-18","modifiedBy":"ONEDATA","dateModified":"2016-03-18","deletedIndicator":"No"},{"value":"NOS1","valueDescription":"NOS1 Gene","ValueMeaning":{"publicId":"5045640","version":"1","preferredName":"NOS1 Gene","longName":"5045640","preferredDefinition":"This gene plays a role in cell-cell signaling, muscle contraction and synaptic transmission.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NOS1 Gene","conceptCode":"C38562","definition":"This gene plays a role in cell-cell signaling, muscle contraction and synaptic transmission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24ADFACE-DDFC-CBE3-E050-BB89AD435CB3","latestVersionIndicator":"Yes","beginDate":"2015-11-16","endDate":null,"createdBy":"COLBERTM","dateCreated":"2015-11-16","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2E581CB6-318F-4BA6-E050-BB89AD4322D6","beginDate":"2016-03-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-03-18","modifiedBy":"ONEDATA","dateModified":"2016-03-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3540235","version":"1","preferredName":"Area Immunohistochemistry Staining Method Biomarker Name","preferredDefinition":"Area is the the extent of a 2-dimensional surface enclosed within a boundary.:Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.:Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc:The words or language units by which a thing is known.","longName":"C25244:C23020:C16342:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Area","conceptCode":"C25244","definition":"The extent of a 2-dimensional surface enclosed within a boundary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Immunohistochemistry Staining Method","conceptCode":"C23020","definition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C64D85C5-7500-4BF3-E040-BB89AD4309F1","latestVersionIndicator":"Yes","beginDate":"2012-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-02","modifiedBy":"ONEDATA","dateModified":"2012-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C64D85C5-7511-4BF3-E040-BB89AD4309F1","latestVersionIndicator":"Yes","beginDate":"2012-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-02","modifiedBy":"REEVESD","dateModified":"2016-03-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5655968","version":"1","longName":"HTMCP (HIV+Tumor Molecular Characterization Project)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000067","version":"1","longName":"HTMCP","context":"OCG"}]}],"AlternateNames":[{"name":"COG","type":"USED_BY","context":"COG"},{"name":"ImmunStainBioNm","type":"COG GDE Short Name","context":"COG"},{"name":"OCG","type":"USED_BY","context":"OCG"}],"ReferenceDocuments":[{"name":"IHC marker name","type":"Preferred Question Text","description":"IHC marker name","url":null,"context":"NCIP"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Stain:","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C64D85C5-7675-4BF3-E040-BB89AD4309F1","latestVersionIndicator":"Yes","beginDate":"2012-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-02","modifiedBy":"TSESU","dateModified":"2017-02-09","changeDescription":"Curated for HTMCP Initiative","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}